Search Results - Nesterova, Alfiya I

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Unravelling the Therapeutic Potential of Antibiotics in Hypoxia in a Breast Cancer MCF-7 Cell Line Model

    Unravelling the Therapeutic Potential of Antibiotics in Hypoxia in a Breast Cancer MCF-7 Cell Line Model by Akhunzianov, Almaz A, Nesterova, Alfiya I, Wanrooij, Sjoerd, Filina, Yulia V, Rizvanov, Albert A, Miftakhova, Regina R

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Cancer of unknown primary and the «seed and soil» hypothesis

    Cancer of unknown primary and the «seed and soil» hypothesis by Zolotykh, Mariya A., Mingazova, Leysan A., Filina, Yuliya V., Blatt, Nataliya L., Nesterova, Alfiya I., Sabirov, Alexey G., Rizvanov, Albert A., Miftakhova, Regina R.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial

    Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-do... by Oliveira, Mafalda, Pominchuk, Denys, Nowecki, Zbigniew, Hamilton, Erika, Kulyaba, Yaroslav, Andabekov, Timur, Hotko, Yevhen, Melkadze, Tamar, Nemsadze, Gia, Neven, Patrick, Vladimirov, Vladimir, Zamagni, Claudio, Denys, Hannelore, Forget, Frédéric, Horvath, Zsolt, Nesterova, Alfiya, Ajimi, Maxine, Kirova, Bistra, Klinowska, Teresa, Lindemann, Justin P O, Lissa, Delphine, Mathewson, Alastair, Morrow, Christopher J, Traugottova, Zuzana, van Zyl, Ruaan, Arkania, Ekaterine

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Abstract GS3-02: GS3-02 Camizestrant, a next generation oral SERD vs fulvestrant in post-menopausal women with advanced ER-positive HER2-negative breast cancer: Results of the randomized, multi-dose Phase 2 SERENA-2 trial

    Abstract GS3-02: GS3-02 Camizestrant, a next generation oral SERD vs fulvestrant in post-menopausal women with advanced ER-positive HER2-negative breast cancer: Results of the rand... by Oliveira, Mafalda, Pominchuck, Denys, Nowecki, Zbigniew, Hamilton, Erika, Kulyaba, Yaroslav, Andabekov, Timur, Hotko, Yevhen, Melkadze, Tamar, Nemsadze, Gia, Neven, Patrick, Semegen, Yuriy, Vladmirov, Vladmir, Zamagni, Claudio, Denys, Hannelore, Forget, Frederic, Horvath, Zsolt, Nesterova, Alfiya, Bennett, Maxine, Kirova, Bistra, Klinowska, Teresa, Lindemann, Justin, Lissa, Delphine, Mathewson, Alastair, Morrow, Christopher, Traugottova, Zuzana, Van Zyl, Ruaan, Arkania, Ekaterine

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: